Got the Hepatitis When I Was a Baby Do I Need It Again

Hepatitis A

Affliction Issues Immune Globulin Vaccine Recommendations Travel - International For Special Groups Vaccine Rubber Administering Vaccines Contraindications and Precautions Twinrix Vaccine Storage and Handling

Affliction Issues

What is hepatitis A?

Hepatitis A is a liver illness common in many parts of the world and caused by hepatitis A virus (HAV), a picornavirus that causes acute inflammation of the liver. Information technology is not related to the common viruses that crusade hepatitis B or C.

What are the signs and symptoms of hepatitis A?

Illness caused by HAV infection cannot be distinguished from other types of acute viral hepatitis, merely it typically has an precipitous onset that can include fever, malaise, anorexia, nausea, intestinal discomfort, night urine, and jaundice. The likelihood of having symptoms with HAV infection is related to age. In children younger than age vi years, 70% of infections are asymptomatic. When illness does occur in immature children, it is typically not accompanied by jaundice. In older children and adults, infection typically is symptomatic, with jaundice occurring in more 70% of patients.

Hepatitis A signs and symptoms usually resolve in 2-iii months, although x% to xv% of symptomatic people have prolonged illness (usually referred to as relapsing hepatitis A) lasting upward to half-dozen months and should be considered infectious during that fourth dimension.

How is HAV transmitted?

Person-to-person spread through the fecal-oral route is the primary means of HAV transmission. Peak infectivity in infected people occurs during the two week period earlier the onset of jaundice when the concentration of virus in the stool is highest and virtually people are no longer infectious ane week subsequently jaundice onset. Earlier routine vaccination of children was recommended, children were a key source of infection because most infected children had no symptoms and could shed virus in stool for weeks or months. Manual currently occurs primarily amongst susceptible adults.

Common-source outbreaks and desultory cases can occur from exposure to fecally-contaminated nutrient or water. Uncooked HAV-contaminated foods take been recognized as a source of outbreaks. Cooked foods besides can transmit HAV if the temperature during food training is inadequate to kill the virus or if nutrient is contaminated subsequently cooking, as occurs in outbreaks associated with infected food handlers. Manual of the virus from infected nutrient handlers to food service establishment patrons is rare, bookkeeping for 0.two% of the nearly 23,000 outbreak-associated cases of hepatitis A investigated by state health departments during 2016-2019.

Until 2017, United states of america incidence rates of hepatitis A were driven by occasional outbreaks, often linked to viral contagion of imported food. Since 2017, communitywide outbreaks have occurred more oftentimes, predominantly amongst people who are connected by specific risk factors, such as drug apply, and their close contacts.

What is the incubation catamenia for hepatitis A?

HAV can produce either asymptomatic or symptomatic infection in humans after an average incubation menses of 28 days (range: xv–50 days).

How is HAV shed?

In infected people, HAV replicates in the liver, is excreted in bile, and is shed in stool. Peak infectivity occurs during the 2-calendar week period before onset of jaundice or elevation of liver enzymes, when concentration of virus in stool is highest. Concentration of virus in stool declines later on jaundice appears, with most people no longer infectious nigh a week after jaundice appears. Children can shed HAV for longer periods than adults, up to 10 weeks or longer after onset of clinical disease.

How common is HAV infection in the United states of america?

The incidence of hepatitis A in the U.s. increased more than ten-fold from 2015 to 2019, with over 18,800 cases reported to CDC in 2019. This number is an underestimate of the actual number of infections: CDC estimates that about 37,700 cases really occurred in 2019.

Between 2012 and 2015 the number of reported hepatitis A infections ranged from approximately 1200 to 1800 cases every year. Start in 2016, large foodborne outbreaks led to an increase in the number of cases and sustained, large person-to-person outbreaks began, primarily driven past infections among unvaccinated people who use drugs and people experiencing homelessness and their contacts. Since then, persistent person-to-person outbreaks have led to substantial increases in hepatitis A infection, with reported cases increasing by over 50% from 2018 to 2019. More than information regarding ongoing multistate outbreaks can be found here: www.cdc.gov/hepatitis/outbreaks/2017March-HepatitisA.htm.

Do people die from hepatitis A?

Yeah. Death every bit a upshot of fulminant hepatic failure is rare, however, older historic period (over 40 years) and preexisting chronic liver illness increases the adventure of astringent disease and death from hepatitis A. The person-to-person U.Due south. multistate outbreaks that began in 2016 have disproportionately affected adults with chronic liver disease and other health problems related to drug utilize and unstable housing. From 2016 through November 2021, CDC received reports of about 43,000 cases of acute HAV infection. Of these, approximately 61% have been hospitalized and 1% (more than than 400 people) take died.

Who is most at risk for acquiring HAV infection?

People who are at increased chance for acquiring HAV infection include the following:

• Travelers to countries that have high or intermediate endemicity of HAV infection • Men who have sexual activity with men (MSM) • Users of injection and non-injection drugs (in other words, all who use illegal drugs) • People with occupational take a chance of exposure (those who work with HAV-infected non-human primates or researchers handling hepatitis A virus) • People who anticipate shut contact with an international adoptee coming from a state with high or intermediate endemicity of HAV infection • People living with HIV infection • People experiencing homelessness, including temporary shelters and other unstable living arrangements • People living in group settings for those with developmental disabilities and other settings where hygiene is difficult to maintain • People who are incarcerated

I idea people with clotting cistron disorders were at chance for hepatitis A due to their regular utilise of blood products. Why did ACIP decide to stop recommending routine vaccination of people with clotting factor disorders?

People with clotting cistron disorders were originally recommended to receive hepatitis A vaccine (HepA) in 1996. At that fourth dimension, the process used to brand clotting cistron supplements did not reliably inactivate hepatitis A viruses and recipients of these products had an increased take a chance of HAV infection. Modern claret donor screening and virus reduction steps have drastically reduced that risk. In addition, more than 80% of people with clotting factor disorders now receive recombinant clotting factor concentrates that are sterilized and accept no risk of HAV manual. Equally a result of these factors, people with clotting factor disorders now have no greater gamble of hepatitis A than the general population and are no longer recommended to receive HepA vaccine unless it is otherwise indicated.

Are people with developmental disabilities at risk of HAV infection?

Historically, HAV infection was highly endemic in institutions for people with developmental disabilities equally a result of poor hand hygiene, shut living conditions and diaper use. As fewer children have been institutionalized and as conditions in institutions have improved, the incidence and prevalence of HAV infection have decreased, although outbreaks can occur in these settings. All children with developmental disabilities should receive HepA according to U.Due south. routine vaccine recommendations, including catch up vaccination of all children through age 18 years.

As a strategy to further reduce the risk of hepatitis A outbreaks and accomplish adults in settings with a high proportion of people with risk factors for HAV infection, the current ACIP recommendations advise considering HepA vaccination of residents and staff in facilities where hygiene is hard to maintain, such as group homes for people with developmental disabilities and homeless shelters.

Are people with chronic liver disease at higher run a risk of acquiring HAV infection?

No. People with chronic liver affliction are non at increased risk for acquiring HAV infection. Still, they are at an increased adventure for life-threatening, fulminant (severe and sudden) hepatitis if they become infected with hepatitis A. People considered to accept chronic liver illness include those with hepatitis B or C infection, cirrhosis, fatty liver disease, alcoholic liver disease, and autoimmune hepatitis.

Please discuss the tests usually used to diagnose hepatitis A.

Hepatitis A cannot be differentiated from other types of viral hepatitis on the basis of clinical or epidemiological features lone. Appropriate claret tests must be used.

• Anti-HAV: Total antibody to HAV. This diagnostic examination detects total antibody of both IgG and IgM subclasses of HAV. If positive, it indicates either acute or resolved infection. • IgG anti-HAV: IgG antibody is a bracket of anti-HAV. Information technology appears early in the form of infection, remains detectable for the person's lifetime and provides lifelong protection against disease. Its presence indicates amnesty through either HAV infection or HepA vaccination. • IgM anti-HAV: IgM antibiotic is a subclass of anti-HAV. Its presence indicates a contempo infection with HAV (half-dozen months or less). It is used to diagnose acute (recently acquired) hepatitis A. Because of the risk of false positive IgM anti-HAV results, people should but be tested for IgM anti-HAV if they are symptomatic and suspected of having acute hepatitis A illness. • HAV RNA tests also may exist used to diagnose acute infection through the direct detection of viral RNA in serum or stool.

Total anti-HAV, which appears early in the class of infection, remains detectable for the person's lifetime and indicates lifelong protection against the infection/disease. To ostend a diagnosis of acute HAV infection, serologic testing for IgM anti-HAV is required. In the majority of persons, serum IgM anti-HAV becomes detectable 5 to 10 days earlier onset of symptoms and lasts about 6 months. Even so, there have been reports of persons who test positive for IgM anti-HAV for upwards to a year or more following infection. An educational program on the interpretation of hepatitis A serology is available on the CDC website at www.cdc.gov/hepatitis/resources/professionals/training/serology/training.htm.

Can HAV be transmitted by blood?

Aye. On rare occasions, HAV infection has been transmitted by transfusion of blood or blood products collected from donors during the viremic phase of their infection (i.e., when HAV is in the donor'due south blood). Since 2002, tests to detect the presence of hepatitis A virus RNA in donated plasma have drastically reduced the risk of hepatitis A transmission from products derived from claret plasma.

Is HAV transmitted by saliva?

In experimentally infected nonhuman primates, HAV has been detected in saliva during the incubation menstruum; however, transmission by human saliva has not been reported.

How mutual is HAV transmission in infirmary settings?

Hospital-caused HAV infection is rare. In the past, outbreaks were observed in neonatal intensive care units when infants acquired infection from HAV-infected transfused blood and later on transmitted HAV to other infants and staff. Outbreaks of hepatitis A acquired by transmission from developed patients to healthcare personnel (HCP) are typically associated with fecal incontinence and inadequate manus hygiene, although the bulk of hospitalized patients who have hepatitis A are admitted after onset of jaundice, when they are beyond the point of peak infectivity. Transmission in healthcare settings likewise has resulted from breakdowns in standard infection control practices and transmission from one healthcare provider to another.

How stable is HAV in the environment?

Depending on atmospheric condition, HAV can exist stable in the environs for months; freezing does not inactivate (i.due east., return non-infectious) HAV. HAV is inactivated past heating foods to temperatures greater than 185°F (85°C) for 1 minute. In addition, HAV on surfaces is inactivated by disinfecting surfaces with a ane:100 dilution of sodium hypochlorite (i.eastward., household bleach) in tap water.

Adequately chlorinating h2o through water treatment processes and dilution in public water systems kills HAV. Spas and swimming pools that are fairly treated are not probable to pose a risk for HAV outbreaks.

Practise people with hepatitis A develop chronic disease or can they become repeated infections?

No, there is no chronic (long-term) infection. Even the modest proportion of people who develop relapsing HAV recover after virtually 6 months. Once you accept had HAV infection and recovered, you cannot get it again.

Vaccination Recommendations Back to top

What is the all-time way to prevent HAV infection?

Vaccination with the total series of hepatitis A vaccine (HepA) is the best manner to preclude HAV infection. Allowed globulin (IG) also can be used for curt-term protection in certain situations.

What are the hepatitis A vaccines (HepA) that are approved for use in the United States?

Recommended dosages and schedules of hepatitis A vaccines Vaccine Age group Dose Volume # Doses Schedule Havrix (GSK) 1-18 years 720 El.U.* 0.5 ml 2 0, 6-12 mos. nineteen years and older 1440 El.U.* 1.0 ml two 0, 6-12 mos. Vaqta (Merck & Co.) 1-18 years 25 U** 0.5 ml 2 0, half dozen-18 mos. xix years and older 50 U** 1.0 ml 2 0, 6-xviii mos.

*El.U. = Elisa Units **U = Units

Combination vaccine using hepatitis A and hepatitis B vaccines Vaccine Age group Antigens used Book # Doses Schedule Twinrix (GSK) 18 years and older Havrix (720 El.U.) combined with Engerix-B (20 mcg) 1.0 ml three 0, ane, 6 mos. 4 0, 7, 21-30 days, 12 months***

*** Accelerated schedule may be used for rapid protection prior to travel or for rapid protection of an unexposed but at-risk person who too would benefit from hepatitis B protection. Twinrix is not recommended for employ as mail service-exposure prophylaxis.

Are HepA vaccine brands interchangeable?

Aye, a number of studies indicate that the ii brands of HepA, Havrix (GSK) and Vaqta (Merck), are interchangeable.

Where tin can I find information about vaccine shortages?

For detailed information about HepA shortages, become to CDC's website at world wide web.cdc.gov/vaccines/hcp/clinical-resources/shortages.html.

Who is recommended to receive HepA vaccine?

The Informational Commission on Immunization Practices (ACIP) recommends routine HepA vaccination for the following groups:

• All children at age 1 year (12–23 months) • All children and adolescents age 2 through 18 years who take not previously received HepA should be vaccinated (i.e., routine catch-upwardly vaccination) [2020] • People living with HIV infection [2020] • Travelers age 12 months and older to areas of the world with intermediate or high HAV endemicity. Low endemicity regions include the U.s., Canada, Western Europe, Japan, New Zealand, and Australia. For more information, see the CDC travel wellness website for electric current information about specific countries at www.cdc.gov/travel or the CDC Yellow Volume (wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/hepatitis-a). When in doubt, vaccinate. • Infants historic period vi through eleven months traveling outside the U.s.a. should receive 1 dose when protection against HAV infection is recommended. The travel dose does not count toward the routine HepA series which should be initiated at age 1 twelvemonth with the advisable dose and schedule. In these instances, the child volition receive a total of iii doses of HepA vaccine. • Men who have sex activity with men • Users of illegal drugs, injectable or noninjectable • People who are homeless or in unstable living arrangements, including shelters • Previously unvaccinated people who anticipate having close personal contact with an international adoptee from a state of loftier or intermediate endemicity during the first 60 days following the adoptee's arrival in the U.S. • People who work with HAV-infected nonhuman primates or with HAV in a research laboratory setting • People with chronic liver disease (including but not limited to people with hepatitis B infection, hepatitis C infection, cirrhosis, fat liver disease, alcoholic liver disease, autoimmune hepatitis, or an ALT or AST level persistently greater than twice the upper limit of normal) • People identified during pregnancy to be at risk for HAV infection due to presence of a specific hazard cistron for exposure or at risk for severe outcome from HAV infection (for case, those with chronic liver illness or with HIV infection). • During an outbreak, any unvaccinated person who is identified as at take chances for HAV infection or at run a risk for astringent disease from HAV • Any person who wishes to be allowed to hepatitis A

HepA vaccination is not routinely recommended for healthcare personnel, food handlers, sewage workers, or twenty-four hours care providers considering there is no evidence that their occupational risks of HAV exposure are significantly higher than the full general population. Yet, any person who desires protection from HAV infection may be vaccinated.

For details well-nigh CDC recommendations for the prevention of hepatitis A, see the 2020 recommendations of the Advisory Committee on Immunization Practices (ACIP): www.cdc.gov/mmwr/volumes/69/rr/pdfs/rr6905a1-H.pdf.

What groups of people recommended for routine HepA vaccination were added or removed in the July 2020 ACIP argument?

• [added] All children ages 2 through 18 years not previously vaccinated • [added] All people age one year or older living with HIV infection • [added] People identified to be at risk for HAV infection during pregnancy • [removed] People with clotting factor disorders

Should nosotros give HepA to a person older than age 18 years who requests it?

Yes, unless the person is allergic to any of the vaccine components. HepA vaccination is safe and effective and is recommended for any person who wishes to obtain immunity.

Which children should be routinely vaccinated against HAV infection?

All children should receive ii doses of HepA vaccine first at age i year (i.due east., 12–23 months). The two doses in the series should be administered at least 6 months apart. Any kid age 2 through 18 years not previously vaccinated should be vaccinated. For a copy of the ACIP recommendations on hepatitis A, go to world wide web.cdc.gov/mmwr/volumes/69/rr/pdfs/rr6905a1-H.pdf.

For hepatitis A vaccination, the minimum interval between the two-dose serial is at least half dozen months. Is this the same as 24 weeks?

No. The minimum interval between dose #1 and #2 of HepA vaccine is six calendar months, not 24 weeks.

I have a kid who was given her second dose of hepatitis A vaccine iv months subsequently the first dose. Does it need to be repeated, and if and then, when?

Aye. The 2nd dose was given more than than 4 days before the minimum interval of 6 calendar months, then it is considered invalid and should be repeated. The repeat dose should be administered the proper minimum interval (6 months) subsequently the invalid dose. If this repeat dose is inadvertently given less than 6 months subsequently the invalid dose, it does non demand to be repeated again as long as the interval between the initial HepA vaccine and the most contempo dose is at least 6 calendar months.

What are the recommendations for postexposure prophylaxis (PEP) for hepatitis A?

In 2020, CDC published revised recommendations for hepatitis A postexposure prophylaxis (PEP). Please see the complete PEP recommendations at world wide web.cdc.gov/mmwr/volumes/69/rr/pdfs/rr6905a1-H.pdf, with special attention to Tabular array 4 on page 19 and Appendix B: Provider Guidance on Take a chance Assessment for Hepatitis A Postexposure Prophylaxis, start on page 36.

Healthy people who accept completed the HepA vaccination series at any time practice not need additional PEP if they are exposed to HAV. People who have recently been exposed to HAV and who have not received HepA vaccine previously should receive PEP as before long every bit possible, within 2 weeks of exposure.

People age 12 months and older exposed to HAV inside the by xiv days and who accept not previously completed the HepA vaccine series should receive a unmarried dose of HepA vaccine every bit soon every bit possible. In addition to vaccine, allowed globulin (IG; 0.one mL/kg) may be administered to people older than age forty years depending on the providers' chance assessment. For long-term immunity, the HepA vaccine series should be completed with a second dose at least vi months after the first dose. Nonetheless, the second dose is not necessary for PEP. A second dose should not be administered sooner than vi calendar months after the beginning dose, regardless of HAV exposure risk.

People age 12 months or older who are immunocompromised or accept chronic liver disease, and who have been exposed to HAV within the past 14 days and take not previously completed the HepA vaccination series, should receive both IG (0.1 mL/kg) and HepA vaccine at the same visit in a different anatomic site (for case, separate limbs) every bit soon as possible afterwards exposure. For long-term immunity, the HepA vaccination series should exist completed with a 2nd dose at least six months after the first dose. However, the second dose is not necessary for PEP. A second dose should non be administered sooner than 6 calendar months after the showtime dose, regardless of HAV exposure risk.

People with HIV infection develop protective levels of antibiotic more slowly and are less likely to develop protective antibody levels after vaccination with HepA, especially if their CD4+ count is depression at the time of vaccination. Protection following vaccination of a person with HIV may wane over time. Vaccine should be administered if the exposed individual is not fully vaccinated; nevertheless, CDC also advises clinicians to consider administering IG PEP to an individual with HIV after a loftier-risk exposure (such equally a household or sexual contact) even if the individual has been fully vaccinated.

Twinrix contains one-half the amount of hepatitis A antigen as a standard single-dose adult HepA vaccine. Twinrix should not be used for PEP but may be used to confer protection to at-risk but not yet exposed persons during an outbreak.

Infants younger than age 12 months and persons for whom vaccine is contraindicated should receive IG (0.i mL/kg) instead of HepA vaccine equally soon as possible and inside ii weeks of exposure. MMR and varicella vaccines should not be administered sooner than half dozen months after IG administration in order to avoid possible IG interference with the effectiveness of MMR and varicella vaccines.

When should prevaccination anti-HAV testing for susceptibility be performed?

Prevaccination serologic testing for HAV (measuring either total anti-HAV or IgG anti-HAV) is not indicated for children because of the low prevalence of infection in children. It too is not routinely recommended for adults but may be considered in some settings to reduce costs associated with vaccinating people who are already immune. Prevaccination testing should not be used if it poses a barrier to vaccinating susceptible people, particularly people who are difficult to access.

Prevaccination testing is well-nigh probable to exist cost-effective for adults who were either born in or lived for long periods of time in areas of the world with loftier or intermediate hepatitis A endemicity. When evaluating people from populations with high rates of previous HAV infection, vaccination history also should be obtained, if viable. If testing or vaccination history is non available, do not postpone vaccinating. There is no harm in vaccinating a person who has had natural infection or previous doses of vaccine.

When should postvaccination testing be performed?

Serologic testing for immunity is not necessary after routine vaccination of infants, children or adults. Testing for the presence of anti-HAV antibiotic one calendar month or more afterwards completing the HepA vaccination series is recommended merely for people whose future clinical management depends on knowing their immune status and for whom revaccination might be indicated, such as people living with HIV and other immunocompromised persons (such as transplant recipients and people vaccinated while receiving chemotherapy). In such individuals, if the results of postvaccination testing do not show an adequate immune response (10 mIU/mL or higher), revaccination with a complete serial is recommended, followed by a second postvaccination serologic test. If that second test remains negative, no additional vaccination is recommended; however, the patient should be counseled on strategies to avoid exposure to HAV and the need for IG if an exposure occurs. If vaccination results in seroconversion, insufficient data are available to brand recommendations concerning repeat testing, booster doses or revaccination.

For Special Groups Back to top

Explain the details regarding the recommendation for giving HepA vaccine to people who will be in contact with recently adopted children.

ACIP recommends vaccination against HAV infection for all previously unvaccinated people who anticipate having close personal contact with an international adoptee from a land of high or intermediate endemicity during the first threescore days following the adoptee's arrival in the U.S. In addition to the adoptee's new parents and siblings, this group might include grandparents, other household members, regular babysitters and other caregivers. The first dose of HepA should be given to close contacts every bit soon as adoption is planned, ideally at least 2 weeks earlier the inflow of the adoptee. A second dose should be given no sooner than 6 months after the showtime dose.

ACIP now recommends routine hepatitis A vaccination for people experiencing homelessness. Can you provide a definition of "experiencing homelessness"?

The 2020 ACIP recommendations for the prevention of hepatitis A define a person experiencing homelessness as 1) a person who lacks housing (regardless of whether the person is a member of a family), including a person whose principal residence during the dark is a supervised public or private facility (e.chiliad., shelter) that provides temporary living accommodations and a person who is a resident in transitional housing, 2) a person without permanent housing who might: live on the streets, stay in a shelter, mission, unmarried-room occupancy facility, abandoned building, vehicle, or any other unstable or nonpermanent state of affairs, or three) who is "doubled up", a term that refers to a situation where persons are unable to maintain their housing state of affairs and are forced to stay with a series of friends or extended family members. In addition, previously homeless persons who are to be released from a prison or a hospital might be considered homeless if they do not take a stable housing situation to which they tin return. The instability of a person's living arrangements is critical to the definition of homelessness.

Some people on my team are worried most initiating the HepA vaccine series in people who are homeless considering we may not be able to complete the series or keep up with their records over time. How much of a concern is this?

While a complete series of HepA is recommended for long-term protection, even a single dose of HepA vaccine has been demonstrated to provide protection against hepatitis A for more than 10 years and can foreclose or control outbreaks of hepatitis A. People who are experiencing homelessness may have difficulty protecting themselves from exposure to HAV in other ways because of their living weather. They should be vaccinated when possible and provided a record of immunization. Reporting the HepA vaccination to a state immunization information system as well tin facilitate immunization assessment at hereafter healthcare encounters.

Should healthcare providers (HCP) be vaccinated routinely confronting hepatitis A?

No. A number of studies have shown that HCP are not at significantly increased adventure of HAV infection because of their occupation. However, if HCPs are going to work (or vacation) in a country with a high or intermediate owned charge per unit of HAV infection, they are at risk of HAV infection and should be vaccinated. The only occupational indications for routine HepA vaccination are work with non-human being primates or alive HAV in a laboratory setting.

Should daycare workers be routinely vaccinated against hepatitis A?

No. In the by, outbreaks of hepatitis A occurred amongst children in child intendance centers, infecting employees of those centers, specially those caring for infants and toddlers. Following widespread adoption of early childhood vaccination against hepatitis A, outbreaks in child care centers are now rare.

Why is hepatitis A vaccination recommended for people with chronic liver disease?

Although not at increased risk for HAV infection, people with chronic liver disease are at increased gamble for fulminant hepatitis A, hospitalization and death if they become infected with HAV. For this reason, hepatitis A vaccination is recommended for them.

Why isn't hepatitis A vaccination recommended for sewage and solid waste disposal workers?

In published reports of three serologic surveys conducted among United states wastewater workers and appropriate comparing populations, no substantial or consequent increase in the prevalence of anti-HAV was identified among wastewater workers. No piece of work-related instances of HAV transmission have been reported amongst wastewater workers in the United States. In improver, in the United States, outbreaks of hepatitis A caused by flooding, which can comport raw sewage, take non been reported.

Why is hepatitis A vaccination no longer recommended for people with clotting factor disorders?

People with clotting factor disorders were originally recommended to receive hepatitis A vaccine (HepA) in 1996. At that fourth dimension, the process used to make clotting factor supplements did non reliably inactivate hepatitis A viruses and recipients of these products had an increased adventure of HAV infection. Modern blood donor screening and virus reduction steps accept drastically reduced that chance. In addition, more 80% of people with clotting cistron disorders now receive recombinant clotting factor concentrates that are sterilized and accept no take chances of HAV transmission. Equally a issue of these factors, people with clotting factor disorders now take no greater risk of hepatitis A than the general population and are no longer recommended to receive HepA vaccine unless it is otherwise indicated.

Why is hepatitis A vaccination recommended (and IG non recommended) for infant travelers age 6 through 11 months at risk of exposure to HAV?

Because of measles. Measles is highly communicable and poses a serious threat to the health of unvaccinated infants. For this reason, all infants age 6 through 11 months who travel internationally are recommended to receive a dose of measles, mumps, and rubella vaccine (MMR) to reduce the risk of measles infection during travel.

The antibodies in immune globulin (IG) typically used to forestall HAV infection in infants before the first birthday tin can interfere with the effectiveness of MMR vaccine. An babe who is given IG should not be vaccinated with MMR or varicella vaccines for at to the lowest degree 6 months afterwards IG administration. If an infant historic period 6 through eleven months is traveling to a destination where protection from infection with HAV is desired, ACIP recommends off-characterization use of HepA vaccine (not IG) in addition to MMR. The HepA and MMR doses administered before the start birthday do non count toward the routine vaccination serial of either vaccine: these infant travelers will still demand two doses of HepA and ii doses of MMR when age appropriate.

Tin can pregnant women receive hepatitis A vaccine?

Yes. The ACIP recommends that pregnant women at risk for HAV infection during pregnancy or at adventure for a astringent result from HAV infection should be vaccinated during pregnancy if not previously vaccinated. Pregnant women should be vaccinated for the same indications as non-pregnant women. For boosted information, run across folio 20 of the recommendations: world wide web.cdc.gov/mmwr/volumes/69/rr/pdfs/rr6905a1-H.pdf.

Administering Vaccines Dorsum to summit

By what method should hepatitis A vaccine be administered?

Hepatitis A vaccine (HepA) should be administered intramuscularly (IM), using the appropriate injection site and needle size as determined by the patient's age and torso mass.

Tin HepA vaccine be given meantime with other vaccines?

Yes. Other inactivated and/or live virus vaccines tin can exist administered at the same time as HepA vaccine, but should be given at a dissimilar anatomical site, if possible. If given in the same musculus, separate the injections by a minimum distance of 1 inch.

Is HepA vaccine available to children through the Vaccines for Children (VFC) plan?

Yes, VFC-supported HepA vaccine is available for children 12 months through xviii years who are VFC-eligible. In addition, combination HepA and HepB vaccine (Twinrix; GSK) is besides available for people who are age 18 years who are VFC-eligible.

What happens if dose #2 of HepA vaccine is delayed?

Yous practise not need to offset the series over again. The immunogenicity of 1 dose of HepA vaccine is 94% to 100%; studies have shown persistent protection from a unmarried dose lasting more than 10 years. To ensure optimal long-term protection it is important to administer the 2d dose.

To complete a 21-yr-old patient's HepA vaccine series, how many developed doses should I requite if the patient received a single dose of pediatric HepA vaccine 5 years ago?

A person should receive the dosage of HepA vaccine appropriate for their age at the time of assistants. Yous should give the patient one adult dose of HepA to complete the ii-dose serial. Information technology is non necessary to restart the vaccine serial.

One of our staff gave a dose of pediatric HepA vaccine to an adult patient by mistake. How exercise we remedy this error?

In general, if the mistake is discovered on the same dispensary twenty-four hour period, you can administer the other "half" of the dose on that same 24-hour interval. If the error is discovered later, the dose should not be counted, then the person should be recalled to the office and given a full age-appropriate repeat dose.

If yous requite more an age-appropriate dose (for case, an adult dose of HepA vaccine given to a child), count the dose every bit valid and notify the patient/parent almost the error. There may be an increased hazard of a local adverse reaction when more than than the recommended dose is given. If the error occurred with the first dose of the series the kid should notwithstanding receive the second dose on schedule. Giving a "double" dose for the starting time dose does not negate the need for a second dose.

Avert such errors past checking the vaccine vial label 3 times.

Why does a 15 year one-time who weighs 160 pounds receive a pediatric dose of HepA while his 110-pound mother receives an adult dose (twice the pediatric dose)?

The efficacy data from the clinical trials were based on historic period at time of vaccination, and non on the weight of the individual. Hence, the dosage recommendations reflect this age-based efficacy data. The same holds true for HepB vaccine. In improver, higher response rates are expected in younger people, fifty-fifty if their weights are above the norm.

Could yous please provide more data about Twinrix (the combination hepatitis A and B vaccine) and the 2 schedules for its use?

Twinrix (GSK) is an inactivated combination vaccine containing both hepatitis A virus (HAV) and hepatitis B virus (HBV) antigens. The vaccine contains 720 EL.U. of hepatitis A antigen (half of the Havrix adult dose) and 20 mcg of hepatitis B antigen (the full Engerix-B adult dose).

In the U.Southward., Twinrix is licensed for utilize in people who are historic period eighteen years or older. It can be administered to people who are at risk for both hepatitis A and hepatitis B, such as certain international travelers, people with HIV infection, people with chronic liver affliction not acquired by hepatitis B, men who have sex with men, illegal drug users, or to people who only want to be immune to both diseases. Chief immunization consists of 3 doses given intramuscularly on a 0, 1, and 6 month schedule. In 2007, the FDA also approved a 4-dose schedule for Twinrix. It consists of 3 doses given within iv weeks, followed past a booster dose at 12 months (0, vii days, 21–30 days, and 12 months). The four-dose schedule could benefit individuals needing rapid protection from hepatitis A and hepatitis B, such as people traveling to high-prevalence areas imminently.

Twinrix cannot be used for postexposure prophylaxis.

I have seen adults who have had ane or two doses of Twinrix, but we only carry single-antigen vaccine in our exercise. How should nosotros complete their vaccination series with single-antigen vaccines?

Twinrix is licensed as a three-dose series for people historic period 18 years and older. If Twinrix is not available or if yous choose non to employ Twinrix to complete the Twinrix series, yous should practise the following: If ane dose of Twinrix was given, consummate the series with 2 adult doses of hepatitis B vaccine and two developed doses of hepatitis A vaccine. If ii doses of Twinrix were given, consummate the schedule with 1 adult dose of hepatitis A vaccine and 1 adult dose of hepatitis B vaccine.

Some other way to consider this is as follows:

A dose of Twinrix contains a standard adult dose of hepatitis B vaccine and a pediatric dose of hepatitis A vaccine. Thus, a dose of Twinrix tin can be substituted for whatsoever dose of the hepatitis B series simply not for any dose of the hepatitis A series.

• Whatever combination of 3 doses of adult hepatitis B or 3 doses of Twinrix is a consummate serial of hepatitis B vaccine. • One dose of Twinrix + 2 doses of adult hepatitis A is a complete serial of hepatitis A vaccine. • Two doses of Twinrix + i dose of adult hepatitis A is a complete series of hepatitis A vaccine.

We're thinking of using Twinrix and we're wondering whether we can use it for doses #one and #3 only and apply single antigen hepatitis B vaccine for dose #2?

No. Twinrix contains l% less hepatitis A antigen component than Havrix, GSK's monovalent hepatitis A vaccine [720 vs. 1440 El. U.], then the patient would not receive the recommended dose of hepatitis A vaccine antigen. For this reason, three doses of Twinrix must contain the serial.

Allowed Globulin Back to acme

What is immune globulin (IG)?

Allowed globulin (IG, GamaSTAN, Grifols Therapeutics) is a sterile preparation of full-bodied antibodies (i.e., immunoglobulins) made from pooled homo plasma processed past cold ethanol fractionation. GamaSTAN is the only IG product licensed in the U.s.a. for the prevention of hepatitis A. Only plasma that has tested negative for hepatitis B surface antigen, antibody to homo immunodeficiency virus (HIV), and antibiotic to hepatitis C virus (HCV) is used to produce IG. In improver, the Nutrient and Drug Administration requires that the process used to produce IG include a viral inactivation stride or that last products examination negative for HCV-RNA past polymerase concatenation reaction. Anti-HAV concentrations differ among IG lots and decreasing concentrations have been observed over the by thirty years, probably considering of the decreasing prevalence of previous HAV infection amongst plasma donors. In 2017, the dosing of GamaSTAN for HAV prevention was increased to reflect this change in anti-HAV potency.

How does immune globulin (IG) work?

IG provides protection against HAV infection through passive transfer of antibody. Depending on the IG dosage, protection lasts from 1 to ii months.

When administered for preexposure prophylaxis, a dose of 0.ane mL/kg will provide protection for up to one month and a dose of 0.2 mL/kg volition provide protection for up to 2 months. If longer term protection is required and vaccination is contraindicated, a dose of 0.ii mL/kg tin can be repeated every 2 months. There is no maximum number of times the bimonthly doses of IG may exist repeated equally long as hepatitis A prophylaxis is required.

For postexposure prophylaxis, the recommended dosage is 0.1 mL/kg.

How is IG packaged and how is IG administered?

Intramuscular IG is available in single-use vials (2 mL and 10 mL). It should be administered intramuscularly, preferably in the anterolateral aspects of the upper thigh and the deltoid muscle of the upper arm. Do not utilise the gluteal region equally an injection site considering of the risk of injury to the sciatic nerve.

Does IG crusade adverse events?

Serious agin events from GamaSTAN IG are rare. Anaphylaxis has been reported after repeated administration to people with known immunoglobulin A (IgA) deficiency; thus, IG should not be administered to these people. IG products including GamaSTAN have been associated with the formation of blood clots (thrombosis) after administration, peculiarly if the patient has other risk factors for thrombosis. Patients should be counseled well-nigh this risk.

Can pregnant or lactating women receive IG?

Aye. Pregnancy or lactation is not a contraindication to IG administration if conspicuously needed.

A kid in my practice was given hepatitis A IG (GamaSTAN, Grifols) when she was ten months one-time after her mother tested positive for hepatitis A. She's scheduled for her 12-month-old well-kid visit. Will this affect her vaccination schedule?

Yep. IG may be given any fourth dimension before or afterward inactivated vaccines. However, the antibodies in IG may interfere with the effectiveness of certain live-virus vaccines, such every bit measles, mumps, and rubella (MMR) and varicella vaccines. CDC recommends waiting at least 6 months from the date of IG administration before administering MMR and varicella vaccines.

Which people should get GamaSTAN (IG) for prevention of hepatitis A?

Please see details of the recommendations for the use of IG for the prevention of hepatitis A provided in Table 4 (folio xix) and Appendices A and B of the 2020 ACIP recommendations for the prevention of hepatitis A infection: www.cdc.gov/mmwr/volumes/69/rr/pdfs/rr6905a1-H.pdf.

Below is a brief summary of the recommendations:

Preexposure prophylaxis with IG for travel to areas of intermediate or high hepatitis A endemicity:

• Infants younger than historic period 6 months and other travelers for whom HepA vaccine is declined or contraindicated • Previously unvaccinated people with chronic liver disease vaccinated within 2 weeks of departure may consider IG in improver to vaccination, based upon the clinician's take chances assessment • Previously unvaccinated people who are immunocompromised may consider IG in addition to vaccination, regardless of the timing of vaccination, based upon the clinician's risk assessment • Previously unvaccinated people who are over age 40 years and vaccinated within two weeks of deviation may consider IG in addition to vaccination, based upon the clinician's risk assessment

Postexposure prophylaxis with IG within ii weeks after exposure to hepatitis A virus (HAV):

• Infants under age 12 months • Previously unvaccinated immunocompromised adults (including HIV+), in addition to vaccination • Previously unvaccinated adults with chronic liver affliction, in improver to vaccination • Previously unvaccinated adults over age twoscore years, consider IG in addition to vaccination, based upon clinician hazard assessment • People with HIV infection, previously vaccinated, consider IG following a high-risk exposure (household or sexual contact), based upon clinician take a chance assessment

Travel - International Dorsum to top

Which travelers are recommended to receive HepA vaccine?

Hepatitis A vaccination is recommended for people age 6 months or older who are traveling to or working in an area of the globe at intermediate or loftier take a chance of hepatitis A transmission. Areas of low gamble include the United States, Canada, Nippon, New Zealand, Australia and Western Europe. Visit the CDC's Traveler Health website for more than information virtually specific destinations and current outbreaks or travel notices (https://wwwnc.cdc.gov/travel/). When in dubiety, vaccinate.

What are the recommendations for vaccination of travelers to protect them from hepatitis A virus (HAV) infection?

For details on preexposure protection of international travelers age 12 months and older, refer to Appendix A on folio 35 of the current ACIP recommendations for the prevention of hepatitis A: www.cdc.gov/mmwr/volumes/69/rr/pdfs/rr6905a1-H.pdf.

Good for you people age 12 months through 40 years who are planning travel to an area with high or intermediate HAV endemicity and have non received HepA vaccine should receive a unmarried dose of HepA vaccine as soon as travel is considered and should complete the 2-does serial according to the routine schedule.

People with chronic liver illness also as adults older than 40 years of age, immunocompromised persons, and persons with other chronic medical weather planning to depart to an expanse with high or intermediate HAV endemicity in less than 2 weeks should receive the initial dose of HepA vaccine and may also simultaneously be administered IG at a dissever anatomic injection site (for case in separate limbs).

ACIP revised its recommendations for preexposure hepatitis A vaccination for travelers in 2018 to include vaccination of infants six through 11 months of age. All infants of this age traveling internationally should be given a dose of measles, mumps, rubella vaccine (MMR) earlier travel. Due to the potential interference of hepatitis A immune globulin (IG) with MMR vaccine effectiveness, an off-label dose of HepA vaccine is recommended instead of IG in this situation. The travel-related dose for infants 6–11 months of age should not be counted toward the routine 2-dose series. The routine two-dose HepA and MMR vaccination serial should be initiated at age 12 months according to the routine, historic period-appropriate vaccination schedule.

Infants younger than 6 months and travelers who elect non to receive vaccine or for whom vaccine is contraindicated should receive a single 0.one mL/kg dose of IG before travel when protection against HAV is recommended. If travel is for more ane month, a dose of 0.two mL/kg should be administered. A 0.ii mL/kg dose can exist repeated every 2 months for travel of more than 2 months elapsing.

Tin can Twinrix be used for people planning international travel?

Yes. If time allows, use the standard Twinrix schedule of 3 doses given intramuscularly on a 0, 1, and 6 month schedule. If travel is imminent the accelerated 4-dose Twinrix schedule can be used, which is 3 doses given on days 0, vii, and 21-30 days and a booster dose at 12 months.

We have an adult patient who received the right pediatric series of HepA vaccine as a teenager and is now traveling away. Does the patient demand an developed booster?

No. There is no recommendation for a booster dose of HepA if a patient has completed the two-dose serial at whatever age.

Is it really necessary to vaccinate travelers to Latin America who will be staying in four-star hotels?

Yes. Information have shown that people acquire HAV infection even in such places as four-star hotels located in Latin America.

If a traveler received the first dose of HepA vaccine more than than one year ago and needs to travel abroad imminently, volition the traveler need IG in addition to dose #two prior to leaving?

No. Just give the final dose of HepA vaccine prior to travel.

If an babe younger than age half dozen months receives IG before travel to a hepatitis A endemic area, volition he/she demand HepA vaccine earlier some other trip to a hepatitis A endemic surface area?

Perhaps. Since IG protects against HAV infection for only 1 to 2 months, depending on the dosage given, boosted IG may be needed if the infant is not however age 6 months. One time the kid has reached six months of age, HepA vaccine should be given.

Can VFC-eligible children who travel to HAV-endemic areas receive HepA vaccine under the VFC program?

Yes. ACIP recommends that all children age one year through 18 years should be vaccinated against hepatitis A. VFC HepA vaccine may exist administered to any eligible child, including those recommended for vaccination at vi through 11 months of age every bit a result of travel to an HAV-endemic area.

If a person was built-in and grew up in a country where HAV infection is endemic (east.m., Vietnam, Mexico) and then moved to the United States at age xx, should that person receive HepA vaccine earlier returning to visit his/her homeland?

It depends on whether that person has a history of HAV infection. Unless in that location are medical records that document prior HAV infection, serologic testing for immunity (positive examination for full anti-HAV) is the but style to determine if vaccination is necessary. For people from countries with high rates of HAV infection, such as Vietnam and Mexico, serologic testing might be washed to preclude unnecessary vaccination. The cost effectiveness of serologic testing, nonetheless, should be counterbalanced confronting the possibility of delaying needed vaccination while awaiting test results.

If a person has had HAV infection, should they still receive the vaccine if planning international travel?

No, equally long as there are medical records that document that the person was previously infected with HAV (i.e., positive exam for total anti-HAV). If there is whatsoever doubt that the person actually was infected with HAV, HepA vaccine and/or IG should exist given. The vaccine or IG will non harm a person who is already immune.

Vaccine Rubber Back to top

What reactions might occur after administration of HepA vaccine?

No serious agin events accept been attributed definitively to HepA vaccine. Among adults, the about frequently reported side effects are soreness at the site of the injection and headache. In children, the almost ofttimes reported side effect is soreness at the injection site. The frequency of side effects after assistants of Twinrix is like to those reported when the 2 unmarried-antigen vaccines were administered.

Contraindications and Precautions Back to top

What contraindications and precautions should be followed when administering HepA vaccine?

Hepatitis A vaccine is contraindicated for people with a history of a severe allergic reaction to a previous dose of HepA vaccine or to a vaccine component. As with all other vaccines, there is a precaution when giving it to anyone who is moderately or severely ill.

Tin can pregnant women receive HepA vaccine?

Yes. ACIP recommends that pregnant women at risk for HAV infection during pregnancy or at chance for a severe outcome from HAV infection should exist vaccinated during pregnancy if not previously vaccinated. Meaning women should be vaccinated for the same indications equally non-pregnant women. For boosted details, come across page xx of the current ACIP recommendations: world wide web.cdc.gov/mmwr/volumes/69/rr/pdfs/rr6905a1-H.pdf.

Can lactating women receive HepA vaccine?

Yes. HepA vaccine is an inactivated vaccine and poses no harm to the nursing babe.

Can HepA vaccine exist given to immunocompromised people?

Yep. All people age 1 year or older living with HIV infection should be vaccinated against hepatitis A if they have non been vaccinated, regardless of their CD4+ count.

If any immunocompromised person has a risk cistron that places them at increased risk of hepatitis A (e.g., international travel, drug use), they should be vaccinated with HepA vaccine.

I have a patient on interferon for hepatitis C, only I want to give him HepA vaccine. Is it okay to vaccinate him against hepatitis A while he is on interferon?

Yes. HepA vaccine should be given to all susceptible patients with chronic liver illness. HepA vaccine is very immunogenic.

Vaccine Storage and Handling

How should HepA vaccine be stored?

All hepatitis A-containing vaccine should be stored at refrigerator temperature at ii°C to 8°C (36°F to 46°F). The vaccine must non exist frozen. Any vaccine exposed to freezing temperature should not be used. Do not use these or any other vaccines after the expiration date shown on the packaging. Any vaccine administered afterwards its expiration date is non valid and should be repeated.

Back to superlative

jacksoncionew.blogspot.com

Source: https://www.immunize.org/askexperts/experts_hepa.asp

Share this post